| Dec 19, 2025 |
Dec 23, 2025 |
TScan Therapeutics, Inc.
|
10% Owner |
Buy |
82.5
|
+161,801
|
1.02%
|
✗
|
$145.5K |
| Oct 28, 2025 |
Oct 30, 2025 |
Cullinan Therapeutics, Inc.
|
10% Owner |
Buy |
87.5
|
+165,667
|
1.88%
|
✗
|
$1.4M |
| Oct 21, 2025 |
Oct 23, 2025 |
Neuphoria Therapeutics Inc.
|
10% Owner |
Buy |
100.0
|
+639,110
|
270.56%
|
✗
|
$3.3M |
| Oct 14, 2025 |
Oct 21, 2025 |
Cullinan Therapeutics, Inc.
|
10% Owner |
Buy |
87.5
|
+248,749
|
1.45%
|
✗
|
$2.1M |
| Oct 8, 2025 |
Oct 10, 2025 |
Cullinan Therapeutics, Inc.
|
10% Owner |
Buy |
96.3
|
+1,459,641
|
9.91%
|
✗
|
$9.8M |
| Sep 11, 2025 |
Sep 15, 2025 |
Passage BIO, Inc.
|
10% Owner |
Buy |
87.5
|
+32,008
|
2.70%
|
✗
|
$223.7K |
| Jul 22, 2025 |
Jul 24, 2025 |
Passage BIO, Inc.
|
10% Owner |
Buy |
97.5
|
+128,848
|
13.72%
|
✗
|
$733.8K |
| May 19, 2025 |
May 21, 2025 |
TScan Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+2,588,794
|
21.39%
|
✗
|
$3.1M |
| Dec 27, 2024 |
Dec 31, 2024 |
Passage BIO, Inc.
|
10% Owner |
Buy |
87.5
|
+373,645
|
4.21%
|
✗
|
$241K |
| Dec 12, 2024 |
Dec 16, 2024 |
TScan Therapeutics, Inc.
|
10% Owner |
Buy |
85.0
|
+131,800
|
1.26%
|
✗
|
$385.8K |
| Nov 25, 2024 |
Nov 27, 2024 |
Passage BIO, Inc.
|
10% Owner |
Buy |
90.0
|
+456,353
|
2.67%
|
✗
|
$284.5K |
| Nov 15, 2024 |
Nov 19, 2024 |
TScan Therapeutics, Inc.
|
10% Owner |
Buy |
47.5
|
+947
|
0.02%
|
✗
|
$4.1K |
| May 31, 2023 |
Jun 2, 2023 |
TScan Therapeutics, Inc.
|
10% Owner |
Sell |
40.0
|
-25,400
|
-0.24%
|
✗
|
$64K |